F-group (family)
2003.1.1.32 CoA_binding
Ligands and drugs
519
Member domains
165
with ligand contacts (≤ 4 Å)
31.8% of members
160
with DrugDomain annotations
30.8% of members
124
with a DrugBank compound
23.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.1.32 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01992 | COA | Coenzyme A | 65 |
| DB14128 | NAD | Nadide | 28 |
| DB00157 | NAI | NADH | 4 |
| DB02637 | OAA | Oxaloacetate Ion | 4 |
| DB00171 | ATP | ATP | 2 |
| DB01829 | DCA | Desulfo-coenzyme A | 2 |
| DB04315 | GDP | Guanosine-5'-Diphosphate | 2 |
| DB16833 | ADP | Adenosine disphosphate | 2 |
| DB00139 | SIN | Succinic acid | 1 |
| DB02082 | GNP | Phosphoaminophosphonic acid guanylate ester | 1 |
| DB02831 | 2HP | Dihydrogenphosphate | 1 |
| DB03725 | GCP | 5'-Guanylylmethylenebisphosphonate | 1 |
| DB11936 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| COA | COENZYME A | 72 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 24 |
| Q5B | (3S)-citryl-Coenzyme A | 19 |
| MGmetal | MAGNESIUM ION | 15 |
| ACO | ACETYL COENZYME *A | 14 |
| CAmetal | CALCIUM ION | 5 |
| NAI | 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE | 4 |
| NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | 4 |
| CL | CHLORIDE ION | 3 |
| 7A2 | 3-C-carboxy-2-deoxy-L-threo-pentaric acid | 2 |
| 8NA | alpha-Diphosphopyridine nucleotide | 2 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 2 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 2 |
| DCA | DESULFO-COENZYME A | 2 |
| ZNmetal | ZINC ION | 2 |
| 2HP | DIHYDROGENPHOSPHATE ION | 1 |
| OAA | OXALOACETATE ION | 1 |
| TUY | (3S,5S,9R,20R,21R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9,20,21-pentahydroxy-8,8-dimethyl-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphadocosan-22-oic acid 3,5-dioxide (non-preferred name) | 1 |
| W1K | 6-[4-[6-[2-[3-[[4-[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethylsulfanyl]-5,5-dimethyl-6-oxidanylidene-hexyl]phenyl]-2,2-dimethyl-hexanoic acid | 1 |